Jefferies initiated coverage on Markel Group with a new price target
$MKL
Property-Casualty Insurers
Finance
Jefferies initiated coverage of Markel Group with a rating of Buy and set a new price target of $1,750.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/2/2024 | $1986.00 → $1836.00 | Buy → Hold | TD Cowen |
| 7/9/2024 | $1986.00 | Buy | TD Cowen |
| 3/15/2024 | $1600.00 | Buy → Neutral | Janney |
| 2/5/2024 | $1680.00 → $1500.00 | Buy → Hold | Jefferies |
| 1/8/2024 | $1475.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 11/22/2023 | $1275.00 | Sell | Citigroup |
| 9/7/2023 | $1750.00 | Buy | Jefferies |
| 12/22/2022 | $1550.00 | Buy | Janney |
SC 13G/A - MARKEL CORP (0001096343) (Subject)
SC 13G/A - MARKEL CORP (0001096343) (Subject)
4 - MARKEL GROUP INC. (0001096343) (Issuer)
4 - MARKEL GROUP INC. (0001096343) (Issuer)
4 - MARKEL GROUP INC. (0001096343) (Issuer)
8-K - MARKEL GROUP INC. (0001096343) (Filer)
13F-HR - MARKEL GROUP INC. (0001096343) (Filer)
10-Q - MARKEL GROUP INC. (0001096343) (Filer)
RICHMOND, Va., May 7, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) will redeem for cash all of its outstanding Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, no par value (the Series A Preferred Shares), effective June 1, 2025 (the Redemption Date) at a price of $1,000 per share, which is equal to the per-share liquidation preference of the Series A Preferred Shares. Since the Redemption Date is not a business day, the redemption will be processed on June 2, 2025. There are currently 600,000 Series A Preferred Shares outstanding with an aggregate liquidation preference of $600.0 million.
RICHMOND, Va., April 30, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) today reported its financial results for the first quarter of 2025. The Company also announced today it filed its Form 10-Q for the quarter ended March 31, 2025 with the Securities and Exchange Commission. "The first quarter was a productive one at Markel Group. Our cornerstone insurance business moved along its path to better. We experienced a lower than initially anticipated impact from the California wildfires. Excluding that impact, our combined ratio returned to the low nineties. We also elevated S
RICHMOND, Va., April 24, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) announced today it will hold a conference call on Thursday, May 1, 2025 beginning at 9:30 am (Eastern Time) to discuss quarterly results and business developments. Investors, analysts and the general public may listen to the call via live webcast at ir.mklgroup.com. The call may be accessed telephonically by dialing (888) 660-9916 in the U.S., or +1 (646) 960-0452 internationally, and providing Conference ID: 4614568. A replay of the call will be available on our website approximately one hour after th
TD Cowen downgraded Markel Group from Buy to Hold and set a new price target of $1,836.00 from $1,986.00 previously
TD Cowen initiated coverage of Markel Group with a rating of Buy and set a new price target of $1,986.00
Janney downgraded Markel Group from Buy to Neutral and set a new price target of $1,600.00
RICHMOND, Va., May 7, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) will redeem for cash all of its outstanding Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, no par value (the Series A Preferred Shares), effective June 1, 2025 (the Redemption Date) at a price of $1,000 per share, which is equal to the per-share liquidation preference of the Series A Preferred Shares. Since the Redemption Date is not a business day, the redemption will be processed on June 2, 2025. There are currently 600,000 Series A Preferred Shares outstanding with an aggregate liquidation preference of $600.0 million.
LONDON, May 7, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today announced the launch of its Clinical Trials insurance product – underscoring its commitment to providing best-in-class solutions to support clinical trials research and product development on an international scale. The new clinical trials offering provides comprehensive cover to sponsors, researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth
Nashville, TN, May 05, 2025 (GLOBE NEWSWIRE) -- Velocity HoldCo, LLC ("Velocity" or the "Company"), the former parent company for Velocity Specialty Insurance Company ("VSIC") and Velocity Risk Underwriters, LLC ("VRU"), announced the sale of VSIC to FM, a leading property mutual insurance company. This transaction follows the earlier sale of VRU to Ryan Specialty (NYSE:RYAN) which together represents a full exit of Oaktree Capital Management, L.P.'s ("Oaktree") interests in Velocity through a transformative three-way transaction. In partnership with Oaktree, Velocity has achieved significant milestones since 2022. Oaktree acquired VRU from Markel (NYSE:MKL) in a strategic carve-out with
4 - MARKEL GROUP INC. (0001096343) (Issuer)
4 - MARKEL GROUP INC. (0001096343) (Issuer)
4 - MARKEL GROUP INC. (0001096343) (Issuer)
Markel's US and Bermuda operations to split into two divisions: US Wholesale and Specialty and Programs and SolutionsWendy Houser appointed President, US Wholesale and SpecialtyAlex Martin appointed President, Programs and SolutionsAndrew McMellin appointed President, International Glenn Harris appointed Chief Commercial OfficerHenry Gardener appointed Chief Risk OfficerRICHMOND, Va., April 22, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today announced a new divisional structure for its US and Bermuda operations and new leadership appointments. The changes, effective today, follow the appointment of Simon Wilson as Chief Executive Off
RICHMOND, Va., March 17, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) announced today that Simon Wilson, currently President of Markel International, has been appointed Chief Executive Officer of the company's three primary underwriting businesses—Markel Specialty, Markel International, and Markel Global Reinsurance—which will collectively be referred to as Markel Insurance. This leadership transition is part of a broader effort to sharpen the company's customer focus by empowering each of their teams to serve the distinct needs of their respective markets—an approach that propelled Markel's growth from a small U.S. insurer when it went public in 1986 to a global specialty insurance lea
RICHMOND, Va., March 17, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE:MKL) announced today that Anthony F. (Tony) Markel, Vice Chairman of the Board, informed the company that he will not stand for re-election at the company's annual meeting of shareholders in May. Mr. Markel will retire as a director of the company at the end of the meeting, at which time he will assume the honorary position of Chairman Emeritus of the Board. Markel Group also announced the appointment of Jon Michael to its Board of Directors, effective March 15, 2025. Mr. Michael is a proven specialty insur